Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
SAB Biotherapeutics, Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
SAB Biotherapeutics, Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
SAB Biotherapeutics, Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
SAB Biotherapeutics, Inc.Listing on record | ExerciseD (derivative) | $31.3M | SEC | ||
SAB Biotherapeutics, Inc.Listing on record | ExerciseD (derivative) | $28.4M | SEC | ||
SAB Biotherapeutics, Inc.Listing on record | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
Provention Bio, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Provention Bio, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Provention Bio, Inc.Listing unverified | Other | $53.3M | SEC | ||
Provention Bio, Inc.Listing unverified | Sell | $53.3M | SEC | ||
Garrett Motion Inc.Listing on record | BuyD (derivative) | $2M | First in 12mo | SEC |